AP2012006117A0 - Pharmaceutical composition of rifampicin. - Google Patents

Pharmaceutical composition of rifampicin.

Info

Publication number
AP2012006117A0
AP2012006117A0 AP2012006117A AP2012006117A AP2012006117A0 AP 2012006117 A0 AP2012006117 A0 AP 2012006117A0 AP 2012006117 A AP2012006117 A AP 2012006117A AP 2012006117 A AP2012006117 A AP 2012006117A AP 2012006117 A0 AP2012006117 A0 AP 2012006117A0
Authority
AP
ARIPO
Prior art keywords
rifampicin
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AP2012006117A
Inventor
Manthan Rohitkumar Trivedi
Deepak Dineshchandra Bhatt
Bakulesh Mafatlal Khamar
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of AP2012006117A0 publication Critical patent/AP2012006117A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
AP2012006117A 2009-07-23 2010-07-22 Pharmaceutical composition of rifampicin. AP2012006117A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1698MU2009 2009-07-23
PCT/IB2010/001777 WO2011010214A1 (en) 2009-07-23 2010-07-22 Pharmaceutical composition of rifampicin

Publications (1)

Publication Number Publication Date
AP2012006117A0 true AP2012006117A0 (en) 2012-02-29

Family

ID=43498820

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006117A AP2012006117A0 (en) 2009-07-23 2010-07-22 Pharmaceutical composition of rifampicin.

Country Status (4)

Country Link
AP (1) AP2012006117A0 (en)
RU (1) RU2012104843A (en)
WO (1) WO2011010214A1 (en)
ZA (1) ZA201200531B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3558300B1 (en) * 2016-12-21 2021-11-24 Tioga Pharmaceuticals, Inc. Solid pharmaceutical formulations of asimadoline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439891A (en) * 1993-10-29 1995-08-08 Kapil; Randhir S. Process for preparation of pharmaceutical composition with enhanced activity for treatment of tuberculosis and leprosy
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
IN186315B (en) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
EP1307199A2 (en) * 2000-08-09 2003-05-07 Panacea Biotec Limited Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
ES2277067T3 (en) * 2002-04-04 2007-07-01 Cadila Pharmaceuticals Limited PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT CONTAINS AN ANTIRETROVIRICAL PROTASA INHIBITOR WITH AN IMPROVED BIODISPONIBILITY.

Also Published As

Publication number Publication date
ZA201200531B (en) 2012-10-31
WO2011010214A1 (en) 2011-01-27
RU2012104843A (en) 2013-08-27

Similar Documents

Publication Publication Date Title
HK1231408A1 (en) Pharmaceutical composition
HK1218881A1 (en) Pharmaceutical compositions
EP2451274A4 (en) Pharmaceutical compositions
EP2379077A4 (en) Pharmaceutical composition
EP2500038A4 (en) Pharmaceutical composition for external use
ZA201104670B (en) Pharmaceutical composition comprising aleglitazar
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
ZA201200659B (en) Pharmaceutical composition of isoniazid
IL219018A0 (en) Pharmaceutical compositions
GB0919650D0 (en) Pharmaceutical composition
GB0917775D0 (en) Novel pharmaceutical compounds
AP2012006117A0 (en) Pharmaceutical composition of rifampicin.
GB0917774D0 (en) Novel pharmaceutical compounds
HU0900010D0 (en) Improved pharmaceutical composition
GB0901241D0 (en) Pharmaceutical compositions